Notable Monday Option Activity: DELL, FFIV, CVS

Options activity in F5 Networks and CVS Health spiked sharply: FFIV saw 7,250 contracts trade (≈725,000 underlying shares), about 64.4% of its one‑month average daily share volume, concentrated in 3,009 contracts of the $240 call expiring Jan. 16, 2026 (≈300,900 shares). CVS registered 41,298 option contracts (≈4.1 million shares), about 54.8% of its one‑month average daily volume, with 23,549 contracts in the $82 call expiring Nov. 21, 2025 (≈2.4 million shares). The size and concentration of these trades—especially in specific strikes and expirations—represent substantial, likely institutional positioning that could signal bullish bets or hedged exposure and may influence near‑term volatility and price action in both stocks.

Analysis

F5 Networks (FFIV) saw 7,250 option contracts trade today, equivalent to ~725,000 underlying shares and roughly 64.4% of its one‑month average daily volume of 1.1 million shares; the activity was concentrated in 3,009 contracts of the $240 call expiring Jan. 16, 2026 (≈300,900 shares), indicating a large, concentrated directional or hedged position in that strike and expiration. CVS Health (CVS) recorded 41,298 option contracts (~4.1 million underlying shares), equal to ~54.8% of its one‑month ADV of 7.5 million shares, with extreme concentration in 23,549 contracts of the $82 call expiring Nov. 21, 2025 (≈2.4 million shares). The size and strike concentration in both names are consistent with institutional-scale bullish exposure or complex hedging; because the CVS position is clustered in a near‑dated Nov. 21, 2025 expiry and the FFIV trade sits in a Jan. 16, 2026 contract, the market impact profile differs (CVS may drive very near‑term gamma and pin risk while FFIV represents longer‑dated directional conviction). Absent confirmation of accompanying stock buys or known strategy details, these flows imply increased short‑term implied volatility and potential price pressure but remain ambiguous as to pure directional commitment versus structured hedging, so monitoring IV, open interest and underlying volume is critical.

Key Decisions for Investors

• Monitor intraday stock price, trading volume, changes in open interest and implied volatility for FFIV and CVS to see whether option flows translate into underlying buying before adding directional exposure
• Avoid initiating uncovered short‑dated option shorts into the CVS Nov. 21, 2025 expiry given concentrated $82 call activity; prefer hedged structures (e.g., call spreads) or wait for expiry clarity
• If pursuing bullish exposure to FFIV, consider defined‑risk long call spreads into the Jan. 16, 2026 strikes to participate in the move while limiting premium risk and sensitivity to IV spikes